Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Steve Baker who wrote (335)	10/9/1998 6:22:00 PM
From: simarx	Read Replies (1) \| Respond to of 420

NOVACARE INC. (NYSE: NOV) Novacare was recently downgraded and took a plunge from 10 + to the recent lows in the 2's. The company is grossly undervalued and does not deserve to be at these levels. In fact, we have been watching NOV's Level 2 Box and the prints. There appears to be great buy pressure and it is growing. Summary of current fundamentals Book Value approximately $9! (It is trading at 2 1/2)! Market Cap is $136.8 Mil while the company has sales of $1.67 Billion LOW P/E of 2.37 We believe the downgrade and earnings news from the company is already built into the price (Look at the chart.) This company is grossly under-valued. This is a speculative buy recommendation but the fundamentals suggest that the company is low risk long-term and a good possibility for a short-term percentage gain. Current bid is 2 1/2 Good fortune to all. Related Yahoo Finance Link on Novacare: biz.yahoo.com Source: investoralley.com

To: Steve Baker who wrote (335)	10/10/1998 9:53:00 PM
From: Kelvin Taylor	Read Replies (1) \| Respond to of 420

Steve- I think what Todd is saying relates to two things. First NOV is going to report lower earnings. In this market there is absolutely no tolerance for disappointment. Since the numbers are going to be 50% less than last year, the belief among the larger investors (mostly institutions) is what happens next quarter? Is this a prelude to a string of lower earnings for '99? The answer to that question is still unknown. Still the PE is very attractive compared to many other stocks in the same industry. The second reason for the decline is overall dislike of small cap stocks. They have been beaten unmercifully for quite some time. My guess on the stock is most if not all of the bad news has already been factored in the price. At 2.5 a share and the same with the PE, it's not likely to remain a low price stock for a prolonged period of time. The concern I have is will the stock trade in a narrow range until the next quarter is finished. I don't know so right now I'm on the sidelines watching, but not buying. I want to see how the stock reacts at the time earnings are announced. It is, however, worth remembering that if a company pre-announces bad earnings the stock takes an immediate hit then recovers some when the numbers are actually released. Will that happen this time around? Just depends on how the market is behaving when they talk. Good Luck, Kelvin